Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Have they done any studies on their drugs and Covid?

<< Previous

Bullboard Posts

Next >>

Comment by qwerty22on Nov 30, 2021 4:13pm

72 Views

Post# 34182114

RE:RE:Have they done any studies on their drugs and Covid?

so much intra-day volatility!

SPCEO1 wrote: I have not heard of any studies regarding either of TH's drugs with regard to covid and do not expect to hear of any either. If Pfizer's new therapeutic drug works as it is expected to, the pandemic may soon be effectively over anyway. People may still get infected but they will not die or even be hospitalized.

Dcutter101 wrote: Antivirals seem to be the best treatment (yes ivermectin) and with all the HIV correlations, isn't it worth a study? Anything and everything please